Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation.
Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
🎥Charles Parker, MBBS, of @uclcancer explores the role of digital pathology and AI-derived models in guiding treatment decisions for high-risk prostate cancer:
American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online
The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation.
Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
🎥Charles Parker, MBBS, of @uclcancer explores the role of digital pathology and AI-derived models in guiding treatment decisions for high-risk prostate cancer:
Lung Cancer Sessions: BTOG 2022 highlights & UK lung cancer care
Watch leading UK lung cancer experts Sanjay Popat, Alastair Greystoke, Anna Minchom & Robert Rintoul discuss the important learnings from the British Thoracic Oncology Group (BTOG) Annual Meeting 2022.
Learn about the current status of lung cancer care in the UK, novel therapeutic targets and the deployment of genomic medicine in the UK.